[
    "{\"step_by_step_thinking\": \"OXLUMO (lumasiran) is a medication that belongs to a class of drugs called RNA interference (RNAi) therapeutics. It works by reducing the production of oxalate, a substance that can build up in the body and cause damage in people with primary hyperoxaluria. Primary hyperoxaluria is a rare genetic disorder characterized by the overproduction of oxalate. Given that OXLUMO specifically targets the reduction of oxalate production, it is used for the treatment of primary hyperoxaluria. Therefore, the answer is A. yes.\", \"answer_choice\": \"A\"}"
]